Ms Tang has investment, executive and board experience in industries including finance, real estate, hospitality, pharmaceuticals and technology, as well as across geographies and jurisdictions including Asia-Pacific, Europe and North America. Ms Tang has investment, executive and board experience in industries comprising finance, real estate, hospitality, pharmaceuticals, and technology. Her work spans Asia Pacific, European and North American markets. In the real estate sector, Ms Tang specializes in the evaluation, acquisition, planning, and development of properties encompassing hospitality, port terminals, premium offices density residential complexes, and REITs. She is the Director of investment offices Haiyi Holdings Pte Ltd and Asia Marvel Holdings Ltd, where her projects include the UBS Singapore headquarters, a 1468-unit residential complex, a port terminal in Southern China, and a logistics portfolio acquisition. She is also Chief Executive Officer of Silver City Properties, LLC, a residential property investment and management company in New York. Ms Tang joined the board as an alternate director of TauRx Pharmaceuticals Ltd in 2019. She also handles the communication and strategic planning for her family office's philanthropy including support for education, sports, the Olympic movement, refugee relief and healthcare. She is Member of the Investment Committee and Member of the ESG and Risk Committee Independent.
